Top 50 Most Viewed Posts This Week |
Today This Week Last Week This Month Last Month
|
1. mightycydy: CYDY's Dr. Scott Hansen & The Gates Foundation (1926) (15) |
2. Kgem: I picked up another 150,000 shares at .0029 (1684) (1) |
3. Kgem: Thank you Wrenchman --- you the man. (1571) |
4. Smoking901: Nov. 26th-2024 Effective July 2025, Pink Current (1373) (3) |
5. Kgem: Dr. David L. Dalton founded Health Resources, (1160) (1) |
6. toodles: Quote from BTW BigTimeWinner Tuesday, 06/12/18 (1113) |
7. Go Green: $UNVC Big party happening here very soon. (993) (1) |
8. Rosner: Short Interest Report As of Sat, Aug 3, '13 (957) |
9. Plotinus: “The results from this preliminary study (772) (18) |
10. Kgem: BREAKING NEWS - BREAKING NEWS - BREAKING NEWS (733) (7) |
11. Buddyboy20: Agreed, updates and breaking news are two (693) (9) |
12. sean007: The essence was NEWS2 scores were good...compared (683) (1) |
13. ohm20: Lastly, the Company remains focused on the (675) (36) |
14. Plotinus: Robust newsy update from Cytodyn this morning. (652) (36) |
15. Drano: The drug companies have aggressively marketed (645) (13) |
16. My69z: Gaudinski / GSK / VRC07-523LS: 2019 Pi on (632) (6) |
17. Drano: Half of the people who have heart failure have (619) (14) |
18. Plotinus: If you go to Max’ LinkedIn pay some attention (610) (12) |
19. Go Green: $UNVC THE CHILL IS GONE! HUGE! (610) (5) |
20. Plotinus: It is definitely good news IMHO. LinkedIn (607) (13) |
21. SporadicE: I think Dr. J.is playing this information (588) (20) |
22. docj: Found this on Reddit. It looks familiar so (582) (10) |
23. sean007: The Shareholder letter was packed with Lots of (565) (13) |
24. HouseofCards: I think they absolutely have relevant (563) (4) |
25. KenChowder: Here's the link to the Daily Kos article (558) (6) |
26. cardamine: I suspect maybe that more than one company might (553) (5) |
27. ohm20: I would have to look further into the (543) (21) |
28. Drano: Well, THAT was a conversation stopper. (541) (2) |
29. KenChowder: Yes, nicer to hear that Cytodyn has stirred the (540) (15) |
30. Evil Rabbit: We craved news for months, then get a juicy (536) (22) |
31. Biolyfe: It was released under our stock symbol at Yahoo (533) (5) |
32. Smoking901: In 2017 UNVC had an partnership with "AGRiMED to (533) (4) |
33. Hyperbolic: These exciting findings have been submitted as a (531) (2) |
34. chazzledazzle: The letter laid out quite a bit. Unpublished GBM (528) (3) |
35. ohm20: The theory is that with with primarys' (527) (18) |
36. Mr3Putt: The final results from that study have now also (526) (8) |
37. docj: One wonders why some of this information is put (525) (8) |
38. KenChowder: https://markets.businessinsider.com/news/stocks/c (522) (14) |
39. ohm20: I checked the protocol on Clinical Trials.gov and (520) (8) |
40. Niele: Somewhere in the comments to the article, I found (518) (4) |
41. Plotinus: Diastolic dysfunction is indeed a major issue (517) (11) |
42. sean007: You know its safe...what's to (517) (1) |
43. Buddyboy20: You would think that it would be a "No Brainer" (514) (7) |
44. Katangolo: I would also suspect that upregulation due to (513) (5) |
45. chazzledazzle: Was just re-reading the letter. And thought to (508) (9) |
46. mfglola: Maybe I missed it, but I don't remember the Mild (508) (3) |
47. Riztheinvestor: Agree that was my take. The HIV LATCH study is (500) (3) |
48. mountaineer: What I "feel" about this never works out for me (497) (6) |
49. Evil Rabbit: I feel like the dam is going to break early in (496) (5) |
50. cardamine: just amazing. Reversing fibrosis. PLEASE let's (492) (3) |